Clinical Trial Update: The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate an investigational CAR-T cell therapy for hematologic malignancies, including acute lymphoblastic leukemia, lymphoma,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Investigational CAR-T cell therapy

Snippet

Sponsor: Hebei Senlang Biotechnology Inc., Ltd. | Conditions: Acute Lymphoblastic Leukemia, Lymphoma | NA | Status: RECRUITING